These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31853610)

  • 1. Trends in Contralateral Prophylactic Mastectomy.
    Fairbairn K; Cervantes A; Rayhrer C; Steen S
    Aesthetic Plast Surg; 2020 Apr; 44(2):323-329. PubMed ID: 31853610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contralateral prophylactic mastectomy in an Asian population: a single institution review.
    Sim Y; Tan VK; Ho GH; Wong CY; Madhukumar P; Tan BK; Yong WS; Ng YY; Ong KW
    Breast; 2014 Feb; 23(1):56-62. PubMed ID: 24275318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contralateral Prophylactic Mastectomy in Patients with Breast Cancer.
    Noditi A; Caragheorghe G; Stoleru S; Blidaru A; Bordea CI
    Chirurgia (Bucur); 2021; 116(2 Suppl):73-83. PubMed ID: 33963696
    [No Abstract]   [Full Text] [Related]  

  • 4. Contralateral Prophylactic Mastectomy: Challenging Considerations for the Surgeon.
    Angelos P; Bedrosian I; Euhus DM; Herrmann VM; Katz SJ; Pusic A
    Ann Surg Oncol; 2015 Oct; 22(10):3208-12. PubMed ID: 26259752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
    Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
    Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Contralateral Prophylactic Mastectomy and Other Types of Breast Cancer Surgery, South Carolina, 2005-2013.
    Clerville J; Bolick S; Clugstone S
    J Registry Manag; 2018; 45(1):28-32. PubMed ID: 30183694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of contralateral prophylactic mastectomy and the impact on breast reconstruction.
    Pinell-White XA; Kolegraff K; Carlson GW
    Ann Plast Surg; 2014; 72(6):S153-7. PubMed ID: 24691345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends of Contralateral prophylactic mastectomy at the time of ipsilateral breast tumor recurrence.
    ElSherif A; Armanyous S; Gentle CK; Al-Hilli Z; Valente SA
    Am J Surg; 2022 Mar; 223(3):533-537. PubMed ID: 34924172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contralateral Prophylactic Mastectomy: Factors Predictive of Occult Malignancy or High-Risk Lesion and the Impact of MRI and Genetic Testing.
    Erdahl LM; Boughey JC; Hoskin TL; Degnim AC; Hieken TJ
    Ann Surg Oncol; 2016 Jan; 23(1):72-7. PubMed ID: 26065870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Moderate-Risk Breast Cancer Genes with Contralateral Prophylactic Mastectomy and Bilateral Disease.
    Zhang JQ; Dos Anjos CH; Sevilimedu V; Crown A; Amoroso KA; Pilewskie ML; Robson ME; Gemignani ML
    Ann Surg Oncol; 2023 Nov; 30(12):6990-6999. PubMed ID: 37661222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active Participation in Decision-Making in Contralateral Prophylactic Mastectomy for Patients With Breast Cancer.
    Huang J; Chagpar A
    J Surg Res; 2019 Oct; 242():129-135. PubMed ID: 31075657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
    Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
    Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability.
    Scheepens JCC; Veer LV'; Esserman L; Belkora J; Mukhtar RA
    Breast; 2021 Apr; 56():61-69. PubMed ID: 33621798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should the use of contralateral prophylactic mastectomy be increasing as it is?
    Wood WC
    Breast; 2009 Oct; 18 Suppl 3():S93-5. PubMed ID: 19914552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State Variation in the Receipt of a Contralateral Prophylactic Mastectomy Among Women Who Received a Diagnosis of Invasive Unilateral Early-Stage Breast Cancer in the United States, 2004-2012.
    Nash R; Goodman M; Lin CC; Freedman RA; Dominici LS; Ward K; Jemal A
    JAMA Surg; 2017 Jul; 152(7):648-657. PubMed ID: 28355431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients.
    Chung A; Huynh K; Lawrence C; Sim MS; Giuliano A
    Ann Surg Oncol; 2012 Aug; 19(8):2600-6. PubMed ID: 22396004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer.
    Murphy BL; Hoskin TL; Boughey JC; Degnim AC; Glazebrook KN; Hieken TJ
    Ann Surg Oncol; 2016 Oct; 23(10):3365-70. PubMed ID: 27364506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of contralateral prophylactic mastectomy is influenced by preoperative MRI recommendations.
    Xia C; Schroeder MC; Weigel RJ; Sugg SL; Thomas A
    Ann Surg Oncol; 2014 Dec; 21(13):4133-8. PubMed ID: 24934585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Contralateral Prophylactic Mastectomy Utilization for Small Unilateral Breast Cancer.
    Baskin AS; Wang T; Bredbeck BC; Sinco BR; Berlin NL; Dossett LA
    J Surg Res; 2021 Jun; 262():71-84. PubMed ID: 33548676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy.
    Yi M; Hunt KK; Arun BK; Bedrosian I; Barrera AG; Do KA; Kuerer HM; Babiera GV; Mittendorf EA; Ready K; Litton J; Meric-Bernstam F
    Cancer Prev Res (Phila); 2010 Aug; 3(8):1026-34. PubMed ID: 20647335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.